Tsai, Joy N <br/><br/>
Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial.  [electronic resource] 

 -  Lancet (London, England)  Jul 2013 
 - 50-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(13)60856-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Area Under Curve<br/>Biomarkers--metabolism<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--administration & dosage<br/>Combined Modality Therapy--methods<br/>Denosumab<br/>Drug Combinations<br/>Female<br/>Humans<br/>Middle Aged<br/>Osteoporosis, Postmenopausal--blood<br/>Teriparatide--administration & dosage<br/>Treatment Outcome